CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-99 Cr | ₹-85 Cr | ₹-100 Cr | ₹31 Cr | ₹-43 Cr |
What is the latest Cash Flow from Financing Activities ratio of CONCORD BIOTECH ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-99 Cr |
Mar2023 | ₹-85 Cr |
Mar2022 | ₹-100 Cr |
Mar2021 | ₹31 Cr |
Mar2020 | ₹-43 Cr |
How is Cash Flow from Financing Activities of CONCORD BIOTECH Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-99 Cr | Negative | |
Mar2023 | ₹-85 Cr | Negative | |
Mar2022 | ₹-100 Cr | Negative | |
Mar2021 | ₹31 Cr | Positive | |
Mar2020 | ₹-43 Cr | - |
Compare Cash Flow from Financing Activities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹17,231.8 Cr | -5.3% | -29.7% | 20.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | -5.3% |
-29.7% |
20.5% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses